The use of inhibitors of methylation could, at least in some cases, stimulate the invasive growth or metastasis of ovarian cancer though reactivation of PIK3CA genes that are silenced by promoter methylation. The gene discussed is PIK3CA; the disease is ovarian carcinoma.